Alendronate-induced esophagitis: Possible pathogenic role of hypersensitivity to alendronate

Internal Medicine

Volumn 47, Issue 23, 2008, Pages 2083-2085

  Naniwa, Taio ^a,b   Maeda, Tomoyo ^a,b   Mizoshita, Tsutomu ^b   Hayami, Yoshihito ^a,b   Watanabe, Maiko ^a,b   Banno, Shogo ^a,b   Ito, Rei ^a,b  

^a NAGOYA CITY UNIVERSITY HOSPITAL   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Adverse event; Alendronate; Bisphosphonate; Drug lymphocyte stimulation test; Esophagitis

Indexed keywords

ALENDRONIC ACID; ALFACALCIDOL; CORTICOSTEROID; DICLOFENAC; FLUVOXAMINE MALEATE; OMEPRAZOLE; PENTAZOCINE; PREDNINE; PREDNISOLONE; UNCLASSIFIED DRUG;

ADULT; ANAPHYLACTOID PURPURA; ARTICLE; CASE REPORT; CLINICAL PROTOCOL; DELAYED HYPERSENSITIVITY; DEPRESSION; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; ESOPHAGITIS; ESOPHAGOSCOPY; FEVER; HUMAN; LYMPHOCYTE TRANSFORMATION TEST; MAINTENANCE THERAPY; MALE; NEPHRITIS; OSTEOPOROSIS; PATHOGENESIS; T LYMPHOCYTE;

ADULT; ALENDRONATE; DRUG HYPERSENSITIVITY; ESOPHAGITIS; HUMANS; MALE;

EID: 61749103586     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.1457     Document Type: Article

References (12)

1. de Groen PC, Lubbe DF, Hirsch LJ, et al. Esophagitis associated with the use of alendronate. N Engl J Med 335: 1016-1021, 1996.
2. Castell DO. "Pill esophagitis" - the case of alendronate. N Engl J Med 335: 1058-1059, 1996.
3. Lieberman UA, Hirsch U. Esophagitis and alendronate. N Engl J Med 335: 1069-1070, 1996.
4. Naylor G, Davies MH. Oesophageal stricture associated with alendronic acid. Lancet 348: 1030-1031, 1996.
5. Colina RE, Smith M, Kikendall JW, Wong RK. A new probable increasing cause of esophageal ulceration: alendronate. Am J Gastroenterol 92: 704-706, 1997.
6. Ryan JM, Kelsey P, Ryan BM, Mueller PR. Alendronate-induced esophagitis: case report of a recently recognized form of severe esophagitis with esophageal stricture - radiographic features. Radiology 206: 389-391, 1998.
7. Bauer DC, Black D, Ensrud K, et al. Upper gastrointestinal tract safety profile of alendronate: the fracture intervention trial. Arch Intern Med 160: 517-525, 2000.
8. Dobrucali A, Tobey NA, Awayda MS, et al. Physiological and morphological effects of alendronate on rabbit esophageal epithelium. Am J Physiol Gastrointest Liver Physiol 283: G576-G586, 2002.
9. Luque I, Leyva L, Jose Torres M, et al. In vitro T-cell responses to beta-lactam drugs in immediate and nonimmediate allergic reactions. Allergy 56: 611-618, 2001.
10. Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 59: 809-820, 2004.
11. Naisbitt DJ, Farrell J, Wong G, et al. Characterization of drugspecific T cells in lamotrigine hypersensitivity. J Allergy Clin Immunol 111: 1393-1403, 2003.
12. Naisbitt DJ, Britschgi M, Wong G, et al. Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T-cell clones. Mol Pharmacol 63: 732-741, 2003.